Overview surgical management of Wegener's granulomatosis · Overview surgical management of...
Transcript of Overview surgical management of Wegener's granulomatosis · Overview surgical management of...
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1312 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
Overview surgical management of Wegener's granulomatosis.
Fahd Hamoud ali Altowairgi, Raad hameed altowairqi, Rayan Darwish Habib, Abdulaziz
Fahad Altowairqi, Rayan Mohammed Alofi
Abstract:
This review goes over the use of interventional surgeries to handle manifestations of Wegener's
granulomatosis triggered by tissue damage and scarring. These symptoms consist of nasal and
paranasal sinus illness, center ear inflammation, nasolacrimal duct obstruction, orbital
inflammatory masses, subglottic stenosis, tracheobronchial illness, and end-stage renal illness. A
search of literature through databases; MIDLINE, and EMBASE was conducted to
identified related articles to our concerned topic (management of Wegener's
granulomatosis) that were published up to November 2017. Wegener's granulomatosis
(WG) is a multisystemic illness advancing with granulomatous inflammation of the respiratory
system and characterized by necrotizing vasculitis and granuloma development, and its
tracheobronchial involvements result in stenosis. Otorhinolaryngologist is the very first physician
to contact for the majority of patients with GPA. Research studies, which showed up recently,
create prospect for the introduction of less harmful and more efficient therapy of GPA with
biological agents. In the advanced stages of WG, the infraglottic JV technique is a great choice
amongst techniques that can be utilized for enabling airway and for performing gas exchange
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1313 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
during surgical treatment conducted for granulations in the upper airway. In this method, the thin
framework of the catheter provides proper vision for surgical procedure and good working
conditions during resection with the CO2 laser and gives safe airway management and gas
exchange for anaesthetists.
Introduction:
Granulomatosis with polyangiitis (GPA) is a rare type of vasculitis. The term Wegener's
granulomatosis has largely been superseded by GPA which is taken into consideration to be a
more precise reflection of its aetiology [1] It is thought to be an autoimmune inflammatory
procedure affecting endothelial cells. It is a multisystem illness which can impact many parts of
the body, categorised by the ELK category: it most generally offers with lesions in the upper
respiratory system (E showing ears/nose/throat, nearly 100%), lungs (L most patients) and
kidneys (K > 75%). Numerous other locations of the body might additionally be affected, with
joint inflammation taking place in 25-50% of all instances. The sinuses, eyes and skin could
additionally be influenced [2], [3]
Subglottic stenosis found in 10-- 20% of WG patients can develop as the first searching for of the
illness or throughout the training course of the disease [5] In this case, the surgical target is to
eliminate the airway blockage by supplying an all-natural airway anatomy. While moderate
situations do not require surgical treatment, more serious set lesions need surgical interventions
such as tracheostomy, laser resection and dilatation [4].
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1314 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
In patients that underwent tracheostomy, granulomas can happen in the tracheal tissue
surrounding the tracheostomy cannula. Endotracheal or tracheostomy tube cuffs lead to pressure
on respiratory tracts and mucosal trauma, and this excessive pressure triggers the formation of a
necrotic location as a circle, leading to eschar and stenosis [6] Moreover, the advancement of
inflammation and granulation tissue can form a severe stenosis in the airway. As a result, after
opening tracheostomy, decanulation of these patients can be difficult because of constant
development of the condition and restenosis. During the surgeries of these patients, airway
control is very important. If surgical treatment is for airway restoration, the scenario can be more
difficult and more complicated. In this instance record, gas exchange and airway management
supplied by jet ventilation (JV) during the excision of granulation tissue, which creates subglottic
stenosis in patients with WG, utilizing endolaryngeal laser surgery is discussed.
Wegener's granulomatosis (WG) is a rare systemic disease associated with necrotizing
granulomatous inflammation in the upper and lower respiratory tract, glomerulonephritis, and
vasculitis. This review goes over the use of interventional surgeries to handle manifestations of
Wegener's granulomatosis triggered by tissue damage and scarring. These symptoms consist of
nasal and paranasal sinus illness, center ear inflammation, nasolacrimal duct obstruction, orbital
inflammatory masses, subglottic stenosis, tracheobronchial illness, and end-stage renal illness.
Methodology:
A search of literature through databases; MIDLINE, and EMBASE was conducted to
identified related articles to our concerned topic (management of Wegener's
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1315 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
granulomatosis) that were published up to November 2017, Following Mesh terms
were used in our search through the MIDLINE; “Wegener's granulomatosis”,
“management”. We limited our search to English language published articles with
human subject.
Discussion:
• Epidemiology
The occurrence of GPA is approximated to be 8- 10 cases per one million depending on
geographical location [7].It has been suggested that the incidence of GPA is increasing,
nevertheless this may just show the accessibility of new analysis techniques and serologic
examinations such as anti-neutrophil cytoplasmic antibodies (ANCAs) that enables a more
constant medical diagnosis [8].The age of signs beginning has a wide distribution with a peak
occurrence at 64- 75 years old [9].
Previous research studies showed that GPA can take place in kids with 8- 15% of cases taking
place in patients age 19 or more youthful [9].Although slight male predominance has been
reported in few instance series [10] a recent research consisting of 158 patients revealed no sex
preference [11].GPA is most frequently reported in white Caucasian patients yet can be seen in
all racial and ethnic groups [11].
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1316 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
• Systemic manifestations
Classic GPA, as detailed by Godman and Churg in 1954 [12], includes the triad of necrotizing
granuloma of upper and lower breathing system, systemic vasculitis, and necrotizing
glomerulonephritis. The kidneys are generally spared in the restricted type of GPA. Classic GPA
can sometimes begin with minimal organ participation and after that transform to a much more
general type with nose, lung and kidney being influenced [14]. Patients with GPA generally
present with nonspecific symptoms of generalized systemic illness consisting of high
temperature, malaise, weight loss, arthralgia, and myalgia [13].
The earliest complaints, which are likewise the most common reasons for seeking medical
attention, are typically connected to upper respiratory tract problems including sinus pain,
purulent nasal discharge, epistaxis, nasal ulcer, and serous otitis media. The existence of clinical
signs such as suppurative otitis, mastoiditis, a saddle-nose defect, and hearing loss need to inform
the physician for GPA.It has been revealed that over 90% of patients with GPA have top
respiratory tract participation [11].A large number of patients present with pulmonary signs
(cough, hemoptysis, dyspnea and less frequently, pleuritic chest discomfort and tracheal
blockage). Reciprocal or independent pulmonary infiltrates exist in nearly 50% of patients
initially, with lung illness at some point establishing in 85- 90% of patients. Pleural effusion has
additionally been reported in 12% of instances [15].Grade Point Average can trigger significant
morbidity and death secondary to diffuse pulmonary hemorrhage [16].
Although kidney participation is clinically obvious in just 11- 20% of cases at presentation,
glomerulonephritis ultimately develops in 77- 85% of patients, usually within the initial two years
of condition beginning [13].Dermatologic involvement has been reported in concerning 50 % of
patients with GPA with purpura including the reduced extremities being one of the most typical
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1317 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
searching for [11].Less typically, ulcers, blisters, papules, subcutaneous nodules and lesions
looking like those of pyoderma may be seen. Arthralgia and myalgia are seen in 70% of patients
[11].Nervous system participation is seen in regarding one-third of patients with outer
neuropathies being one of the most typical [17].Cranial neuropathies, exterior ophthalmoplegia,
seizures, cerebritis and stroke syndromes are additionally important findings. Diabetes insipidus
might take place when granulomas expand from the sinuses into the pituitary gland [17].Cardiac
participation is uncommon, with pericarditis being one of the most constant difficulties (6%).
Ocular manifestations
In a study of 701 North American patients with GPA, 30% of patients were reported to have
ocular participation [21].Other research studies have reported similar findings, with ocular
participation in regarding 50% of the patients [18].Ocular illness can be the presenting or even
the only clinically apparent indication of GPA [19].Straatsma classified the eye involvement as
adjoining or noncontiguous based on the existence or absence of direct extension from the
surrounding engaged sinuses [20].
Serious ocular morbidity with vision loss or overall blindness could be seen in 8- 37% of patients,
specifically if there has been a hold-up in medical diagnosis, or if the condition has been
improperly treated [18].
The Orbit
The orbit is one of the most regularly included ocular structure in GPA, and is more frequently
second to expansion of sinus pathology [19].Symptoms of orbital condition consist of proptosis,
lid edema, diplopia, and decreased vision. Orbital discomfort existed in only 30% of patients in
an Australian cohort. Of patients with orbital involvement, 14- 30% have bilateral illness.
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1318 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
Damages to eye frameworks may result from mass compression, vascular occlusion or spread of
an orbital cellulitis. Proptosis happens in up to one-third of cases [11].GPA can offer as an orbital
mass bring about cranial nerve participation and entrapment of extraocular muscle resulting in
diplopia [22].Additionally, orbital participation could lead to blindness from a compressive
ischemic optic neuropathy [11].In a just recently published National Institutes of Health (NIH)
report, a group of 158 patients with GPA were examined and about half of patients with retro-
orbital participation lost vision [11].Orbital participation has additionally been reported in kids
[23].
The Lacrimal System
Inflammation of the lacrimal gland (dacryoadenitis) has been reported as an offering sign of GPA
[24].This presents with discomfort and edema of the anterior orbit in the superior-temporal region
with swelling of the eyelid and discomfort with eye motion. Nasolacrimal air duct obstruction is a
late searching for and is generally related to nasal involvement [25].Sicca disorder with positive
single strand A/ solitary strand B (SS-A/SS-B) auto-antibodies has additionally been reported.
The Episclera and Sclera
Both scleritis and episcleritis have been formerly reported in patients with GPA. GPA can result
in nodular, diffuse, or necrotizing scleritis with tendency towards a much more severe scleritis
compared with various other etiologies. Necrotizing scleritis could lead to considerable ocular
morbidity with serious vision loss and blindness if not adequately dealt with. Difficulties consist
of globe perforation needing enucleation [26].In necrotizing scleritis, an area of the inflamed
sclera comes to be avascular and ischemic, usually second to occlusive vasculitis. Hoffman et al.
[30] reported scleritis to be the 3rd most usual ocular symptom of GPA adhering to orbital and
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1319 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
nasolacrimal involvement. Necrotizing scleritis has been reported complying with regular cataract
surgical treatment in patients with GPA. In some patients, it has been the here and now indication
of GPA, while in others, it occurred in spite of being in remission [27].
The Cornea
PUK is one of the most considerable corneal complication of GPA. On histopathology, there is an
immune-mediated occlusive necrotizing vasculitis of the anterior ciliary arteries. These arteries
supply the anterior segment of the eye consisting of the sclera, conjunctiva and the outer cornea.
Concentration of this hematologic inflammatory milieu in the peripheral cornea results in
ulceration of the peripheral corneal proteoglycans and collagen. This can advance concentrically
and/or centrally and is usually reciprocal. Owing to the shared blood supply, PUK is often
accompanied by scleritis (generally necrotizing) [28] It has been proposed that necrotizing
scleritis with PUK might define systemic vasculitis [29].While PUK is the prototypical corneal
complication in GPA, numerous various other corneal indications have likewise been described.
Sometimes, the nearby scleral inflammation results in an exudative peripheral keratitis without
ulceration. Stromal (interstitial) keratitis, is a hardly ever defined feature of GPA.
The Uvea
Although uncommon in isolation, intraocular inflammation has been described in patients with
GPA. The uveitis connected with GPA is nonspecific, unilateral or bilateral and can be anterior,
intermediate, or back with or without vitritis [19].An evaluation of a large cohort of patients with
anti-neutrophil cytoplasmic antibodies (ANCA) favorable vasculitis found an incidence of 17.9%
for uveitis: 70% anterior uveitis, 10% intermediate uveitis, and 20% posterior uveitis. The writers
noted that 50% of patients with anterior uveitis had an existing together scleritis (sclera-uveitis),
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1320 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
recommending that usually uveitis was a secondary sensation [31].Additionally a granulomatous
panuveitis has been referred to as the preliminary symptom of GPA [32].
Table 1. Profile of Organ Involvement in Wegener Granulomatosis [19],[31][28].
Organ Site Frequency at Presentation, % Frequency During Disease Course, %
Upper airway 73 92
Lower airway 48 85
Kidney 20 80
Joint 32 67
Eye 15 52
Skin 13 46
Nerve 1 20
• Surgical care
Surgical treatment may be needed for:
o Nasal deformity. o Subglottic stenosis. o Obstruction of lacrimal ducts. o Bronchial stenoses. o Eustachian dysfunction (insertion of grommets). o Acute kidney injury (renal transplant). • Lacrimal drainage surgery in Wegener's granulomatosis
Nasolacrimal air duct blockage in Wegener's granulomatosis most likely takes place as a straight
extension of nasopharyngeal disease and typically is a late manifestation. Postoperative wound
necrosis and the development of nasocutaneous fistula have been reported after DCR in these
patients [33] and dacryocystectomy has been suggested as a therapy for nasolacrimal duct
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1321 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
obstruction in this disease [34].Others have additionally reported much more motivating results
with DCR [35] or have recommended using endoscopic DCR in Wegener's disease [36].
In today series, all the patients offered in the third to 6th years, and either had a short (4- 5 years)
or lengthy (8- 30 years) history of symptoms suitable with Wegener's granuloma. Four patients
(patients 1, 2, 7, and 10) underwent uneventful and effective DCR on their regular maintenance
dose of immunosuppressants and three (patients 6, 8, and 11) achieved symptomatic relief with
perioperative immunosuppression. Patient 3 attained a good outcome with a short course of high
dose prednisolone following discovery of inflamed tissue at the personnel website. In patient 4,
the granulomatous illness had been quiescent for over 10 years, but the comprehensive scarring in
the nose was related to thick membrane layer formation over the rhinostomy and failure; surgical
treatment on the contralateral side, without adjuvant systemic immunosuppression, was curative.
Despite prednisolone and azathioprine cover, there was an intraorbital development of the nasal
granuloma through the rhinostomy in one patient (patient 5), this orbital condition settling with
boosted immunosuppression and later on surgery to the various other eye was straightforward
after giving prophylactic high dosage systemic steroids. Wegener's condition was not
acknowledged in patient 9 and numerous previous attempts of endoscopic laser DCR (before
reference) were without immunosuppression and associated with substantial nasal scarring and
development of a massive intranasal cyst-- these modifications undoubtedly compromising the
definitive lacrimal surgery. Endoscopic DCR may be inappropriate in the visibility of significant
nasal inflammatory illness, as illustrated in this situation, and we take into consideration that the
huge rhinostomy achievable with external surgical treatment could aid in the long term success of
the operation. There have been comparable recommendations for patients with sarcoidosis who
are undergoing lacrimal surgery [37]. On the other hand with a previous record [33] injury death
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1322 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
and nasocutaneous fistula were not seen in our collection and there was just one very early failure
as a result of canalicular occlusion developing in a thoroughly marked nasal space.Open DCR
recommend as a safe and effective therapy for nasolacrimal blockage in patients with controlled
Wegener's granulomatosis. A rise in systemic immunosuppression ought to be considered for a
few weeks after surgical procedure in unstable condition, or when energetic illness is seen during
surgical procedure, and the patient monitored carefully for recurring or spreading postoperative
disease.
• Airway Surgery in Tracheostomised Patients with Wegener Granulomatosis Leading
to Subglottic Stenosis
Subglottic stenosis accompanying the proliferative development of diseased tissue in the direction
of the larynx and trachea in WG can cause airway blockage and require intervention. This
scenario is extra common in the 4th and 5th decades of life, and its symptoms vary from
coughing and lack of breath to serious stridor that is progressively dangerous. Around 16-- 23%
of these patients create subglottic stenosis, and this generally advances with fibrosis and oedema
causing stenosis that is 3- 4 centimeters below the singing cord. In a collection consisting of 7
patients, which was carried out by Alaani et al. [38], in the case of active illness, tracheostomy
was suggested as the initial surgical therapy selection in addition to clinical therapy for dealing
with respiratory system failure. In both our patients, surgical tracheostomy was carried out due to
the advancement of serious respiratory system distress and stridor associated with the progression
of the disease while clinical therapy was being gotten.
The development of the disease continues in patients with tracheostomy, and the formation of
granulomas bordering the tracheostomy cannula and extending downwards creates major stenosis
in the airway.
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1323 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
As necessary, a new medical treatment is needed within the procedure. Lebovics et al. [39]
reported the presence of subglottic stenosis in 25 of 158 patients with WG, and they specified that
the lesion was so significant that some treatments such as dilatation, laser resection or
laryngotracheoplasty would be needed in 16 of these patients. In both our patients, subacute
degeneration on the basis of chronic condition and serious inspiration trouble despite
tracheostomy established, and a brand-new evaluation was demanded. First of all, the exact areas
and levels of sores were identified with the help of pictures obtained via CT, and
tracheobronchoscopy was executed under basic anaesthesia for the intervention plan of therapy.
Throughout basic anaesthesia applied in tracheobronchoscopy, which is performed for the
assessment of the lesion and for preparing surgical treatment and then used in the treatment for
the airway, airway control is necessary. Gao et al. [40] observed tracheal stenosis and dyspnoea
in 12 of 15 patients having a mass in the trachea. In these patients, basic orotracheal intubation
was favored for stenoses, triggering narrowing less than 50% in the throat lumen, and the
tracheostomy was opened in the mass situated in the upper area of the trachea. On the other hand,
in patients with a mass located in the lower area of the trachea and with significant respiratory
distress and hypercarbia, adequate oxygenation can not be provided with the conventional
method. For airway control in these patients, extracorporeal circulation wased initially used, and
passing an endotracheal tube with a stenotic lesion with a fibre-optic bronchoscope was after that
carried out as an alternative method. As another technique, Xu et al. [41] reported that an
adequate surgical site and suitable surgical atmosphere were supplied without any development
of any difficulty by protecting spontaneous respiration under infusion with propofol and
remifentanil without endotracheal intubation in 31 patients that were to undertake upper airway
surgical treatment.
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1324 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
In the 10-year empirical study, Jaquet et al. [42] brought the subglottic JV onward as a choice to
the options of intubation with a little endotracheal tube, tubeless ventilation with the defense of
spontaneous respiration, and apneic oxygenation in the pathologies causing stenosis in the larynx.
The JV method can be assessed as a choice for the resection of granulation tissue with a CO2
laser owing to its thin catheter framework and feature of laser resistance. In our patients, the JV
strategy was used for the resection of granulation tissue, which surrounded the existing
tracheostomy, with a CO2 laser.
Conclusion:
Wegener's granulomatosis (WG) is a multisystemic illness advancing with granulomatous
inflammation of the respiratory system and characterized by necrotizing vasculitis and granuloma
development, and its tracheobronchial involvements result in stenosis. Otorhinolaryngologist is
the very first physician to contact for the majority of patients with GPA. This medical diagnosis
must constantly be taken into consideration in patients with recurring upper respiratory system
infections, otitis, mucosal ulcers and laryngitis. Proper and early diagnosis is crucial for imminent
treatment application and allows avoiding irreparable organ damage. Research studies, which
showed up recently, create prospect for the introduction of less harmful and more efficient
therapy of GPA with biological agents. In the advanced stages of WG, the infraglottic JV
technique is a great choice amongst techniques that can be utilized for enabling airway and for
performing gas exchange during surgical treatment conducted for granulations in the upper
airway. In this method, the thin framework of the catheter provides proper vision for surgical
procedure and good working conditions during resection with the CO2 laser and gives safe
airway management and gas exchange for anaesthetists.
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1325 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
Reference: 1. Jennette JC; Nomenclature and classification of vasculitis: lessons learned from
granulomatosis with polyangiitis (Wegener's granulomatosis). Clin Exp Immunol. 2011 May164 Suppl 1:7-10. doi:
2. Pai S, Panda M; Limited Wegener's granulomatosis presenting as lung nodules in a patient with rheumatoid arthritis: a case report. Cases J. 2008 Dec 231(1):417. doi: 10.1186/1757-1626-1-417.
3. Holle JU, Moosig F, Dalhoff K, et al; Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides. Arthritis Res Ther. 2011 Jun 3013(3):224. doi: 10.1186/ar3307.
4. Yazıcı ZM, Kayhan FT, Erdur Ö, Erol BS. Granülomatoziste KBB tutulumu. KBB ve BBC Dergisi. 2009;17:62–5.
5. Zycinska K, Wardyn K, Zielonka TM, Nitsch-Osuch A, Zarzycki S, Demkow U, et al. Subglottic and tracheal stenosis due to Wegener’s granulomatosis. Adv Exp Med Biol. 2013;755:221–4.
6. Grillo HC, Donahue DM, Mathisen DC, Wain JC, Wright CD. Postintubation tracheal stenosis. J Thorac Cardiovasc Surg. 1995;109:486–92.
7. Ntatsaki E, Watts RA, Scott DG. Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010; 36:447-461.
8. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s ?is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond. 1990; 24:284-288.
9. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS.Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992; 116:488-498.
10. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J. 1958; 2:265-270.
11. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS.Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992; 116:488-498.
12. Godman CC, Churg J. Wegener's granulomatosis: Pathology and review of the literature. AMA Arch Pathol. 1954; 58:533-553.
13. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983; 98:76-85.
14. Specks U, DeRemee RA. Granulomatous vasculitis. Wegener's granulomatosis and Churg-Strauss syndrome. Rheum Dis Clin North Am. 1990; 16:377-397.
15. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest. 1990; 97:906-912.
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1326 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
16. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990; 33:1101-1107.
17. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: An analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993; 33:4-9.
18. Spalton DJ, Graham EM, Page NG, Sanders MD. Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol. 1981; 65: 553-563.
19. Cogan D. Corneoscleral lesions in periarteritis nodosa and Wegener's granulomatosis. Trans Am Ophthalmol Soc. 1955; 53: 321-342.
20. Straatsma BR. Ocular manifestations of Wegener's granulomatosis. Am J Ophthalmol. 1957; 144:789-799
21. Abdou NI, Kullman GJ, Hoffman GS, Sharp GC, Specks U, McDonald T, Garrity J, Goeken JA, Allen NB. Wegener's granulomatosis: Survey of 701 patients in North America. Changes in outcome in the 1990s. TJ Rheumatol. 2002; 29:309-316.
22. Cassan SM, Divertie MB, Hollenhorst RW, Harrison EG., Jr Pseudotumor of the orbit and limited Wegener's granulomatosis. Ann Intern Med. 1970; 72:687-693.
23. 30. Ziakas NG, Boboridis K, Gratsonidis A, Hatzistilianou M, Katriou D, Georgiadis NS. Wegener's granulomatosis of the orbit in a 5-year-old child. Eye. 2004; 18:658-660.]
24. Howe L, D'Cruz D, Chopdar A, Hughes G. Anterior ischaemic optic neuropathy in Wegener's granulomatosis. Eur J Ophthalmol. 1995; 5:277-279.
25. Kalina PH, Garrity JA, Herman DC, DeRemee RA, Specks U. Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudotumor. Mayo Clin Proc. 1990; 65:1110-1117.
26. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984; 91:1253-1263.
27. Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery. A clinicopathologic study. Ophthalmology. 1991; 98:1720-1726.
28. Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Survey of ophthalmology. 1999; 43:379-396.
29. Watson PG, Mason S. Fluorescein angiography in the differential diagnosis of sclerokeratitis. Br J Ophthalmol. 1987; 71:145-151.
30. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS.Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992; 116:488-498.
31. Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, Nussenblatt RB, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Suhler EB, Smith JR. Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor. 2009; 3:12-19.
IJSER
International Journal of Scientific & Engineering Research Volume 8, Issue 12, December-2017 1327 ISSN 2229-5518
IJSER © 2017 http://www.ijser.org
32. Huong du LT, Tran TH, Piette JC. Granulomatous uveitis revealing Wegener's granulomatosis. J Rheumatol. 2006; 33:1209-1210.
33. Jordan DR, Miller D, Anderson RL(1987) Wound necrosis following dacryocystorhinostomy in patients with Wegener's granulomatosis. Ophthalmic Surg 18:800–803.
34. Holds JB, Anderson RL, Wolin MJ(1989) Dacryocystectomy for the treatment of dacryocystitis in patients with Wegener's granulomatosis. Ophthalmic Surg 20:443–444.
35. Hargwig PW, Bartley GB, Garrity JA(1992) Surgical management of nasolacrimal duct obstruction in patients with Wegener's granulomatosis. Ophthalmology 99:133–139.
36. Wong RJ, Gliklich RE, Rubin PA, et al.(1998) Bilateral nasolacrimal duct obstruction managed with endoscopic techniques. Arch Otolaryngol Head Neck Surg 124:703–706.
37. Chapman KL, Bartley GB, Garrity JA, et al.(1999) Lacrimal bypass surgery in patients with sarcoidosis. Am J Ophthalmol 127:443–446.
38. Alaani A, Hogg RP, Drake Lee AB. Wegener’s granulomatosis and subglottic stenosis: management of the airway. J Laryngol Otol. 2004;118:786–90.
39. Lebovics RS, Hoffman GS, Leavitt RY. The management of subglottic stenosis in patients with Wegener’s granulomatosis. Laryngoscope. 1992;102:1341–5.
40. Gao H, Yi J, Huang YG. Airway management and anesthesia for tracheal masses in 15 patients. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013;35:322–6.
41. Xu J, Yao Z, Li S, Chen L. A non-tracheal intubation (tubeless) anesthetic technique with spontaneous respiration for upper airway surgery. Clin Invest Med. 2013;36:151–7.
42. Jaquet Y. Complications of different ventilation strategies in endoscopic laryngeal surgery. Anesthesiology. 2006;104:52–9. IJSER